Early obstructive colon after treatment of active refractory Crohn's disease with infliximab [4];Subocclusion colique précoce après traitement d'une maladie de Crohn réfractaire active par infliximab

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 11, 2003, Pages 1045-1047

  Belaiche, Jacques ^a   Louis, Edouard ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZATHIOPRINE; BUDESONIDE; INFLIXIMAB;

ABDOMINAL PAIN; ADULT; BARIUM ENEMA; CASE REPORT; COLON OBSTRUCTION; COLON STENOSIS; CROHN DISEASE; DIARRHEA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; LETTER;

ADULT; ANTIBODIES, MONOCLONAL; COLONIC DISEASES; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL OBSTRUCTION; TIME FACTORS;

EID: 0344739751     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Cohen RD, Tsang JF, Hanauer SB. Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol 2000;95:3469-77.
2. Farrell RJ, Shah SA, Lodhavia PJ, Alsahli M, Falchuk KR, Michetti P, et al. Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Am J Gastroenterol 2000;95:3490-7.
3. D'haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology 1999;116:1029-34.
4. Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999;116:22-8.
5. Prajapati DN, Saeian K, Kim JP, Kugathasan S, Knox JF, Emmons J, et al. Symptomatic luminal stricture underlies infliximab non-responder in Crohn's disease (abstract). Gastroenterology 2002;122:A100.
6. Vassallo R, Matteson E, Thomas CF, Jr. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest 2002;122:1093-6.
7. Crespo J, Rivero M, Fabrega E, Cayon A, Amado JA, Garcia-Unzeta MT, et al. Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig Dis Sci 2002;47:1604-10.
8. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 2002;169:929-36.